LAKE FOREST, Calif., April 06, 2017 -- InMode Aesthetic Solutions®, a leader in aesthetic medicine and technology, is proud to announce the launch of the brand’s newest procedure, BodyTite. This non-excisional device utilizes radio-frequency assisted lipolysis (RFAL) to address the shortcomings often associated with traditional liposuction or surgical body and face lifts, including sagging or wrinkly skin and scarring, by inserting a wand under the skin to coagulate inside while tightening the skin on top.
With over one hundred surgical practices in North America already utilizing the new technology, doctors can ensure their patients receive surgical-like procedures with limited downtime and without scars. The FDA approved technology, for use on the stomach, arms, chest, knees and inner/outer thighs, is minimally invasive and leaves virtually no scarring. Results can be seen immediately after one treatment and are more evident over three to six months post-treatment.
Previously, patients looking for fat reduction treatments had limited options including multiple non-invasive treatments with limited skin contraction results, a surgical tummy tuck with downtime or a brachioplasty, leaving large excision scars. These options left patients who wanted less invasive procedures without a solution, or unhappy with the results of their treatment. With BodyTite, doctors are able to ensure patients receive minimally invasive, effective procedures and offer powerful aesthetic results.
“Traditional surgery can leave permanent scars, and does not really fix the problem -- soft tissue with no internal support framework,” Diane Duncan, M.D., Fort Collins CO, a practitioner of BodyTite explains. “This new device is providing that internal structure reorganization, and in addition, has been proven to create up to 36.4% skin surface area contraction at one year” (Duncan, Aesthetic Surgery Journal, 2016).
“BodyTite is one of many technological innovations to come from InMode this year,” says Erik Dowell, CEO of InMode North America. “With our enhanced management team, we are looking forward to showcasing the advances we are making to the cosmetic industry to doctors and patients alike.”
About InMode: InMode’s technological advancements have become the new standard for aesthetic medicine, specifically in the radio-frequency aesthetic market. For more than three decades our R&D team was critical in developing state-of-the-art light, laser and radio-frequency devices, thereby launching and shaping the industry. Our technology continues that legacy in providing superior satisfaction for both the patient and the practice. Learn more about InMode technologies by visiting www.inmodemd.com.
Press Contact: Gianna Visconti | The Woods & Co [email protected] | 212.838.1878


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 



